Biophytis (Biophytis) Stock Based Compensation : $0.88 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biophytis Stock Based Compensation?

Biophytis's Stock Based Compensation for the six months ended in Dec. 2023 was $0.53 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $0.88 Mil.

Biophytis Stock Based Compensation Historical Data

The historical data trend for Biophytis's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Stock Based Compensation Chart

Biophytis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

0.07

0.96

3.86

5.90

0.88

Biophytis Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial															3.02	3.73	2.15	0.35	0.53

Biophytis Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.88 Mil.

Biophytis Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Biophytis's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biophytis (Biophytis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

ALBPS:France 6XB:Germany

Address

BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005

Website

https://www.biophytis.com

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.